Texas 2019 - 86th Regular

Texas Senate Bill SR852

Caption

Suspending limitations on conference committee jurisdiction on HB 3284.

Companion Bills

No companion bills found.

Previously Filed As

TX SR716

Suspending limitations on conference committee jurisdiction on HB 3697.

TX SR711

Suspending limitations on conference committee jurisdiction on SB 28.

TX SR691

Suspending limitations on conference committee jurisdiction on S.B. 10.

TX SR693

Suspending limitations on conference committee jurisdiction on H.B. 3447.

TX SR717

Suspending limitations on conference committee jurisdiction, H.B. No. 3699.

TX SR700

Suspending limitations on conference committee jurisdiction, H.B. No. 4635.

TX SR686

Suspending limitations on conference committee jurisdiction on S.B. 1893.

TX SR706

Suspending limitations on conference committee jurisdiction on HB 357.

TX SR708

Suspending limitations on conference committee jurisdiction on SJR 75.

TX HR2431

Suspending limitations on conference committee jurisdiction, H.B. No. 4.

Similar Bills

CA AB2789

Health care practitioners: prescriptions: electronic data transmission.

CA AB852

Health care practitioners: electronic prescriptions.

TX HB2766

Relating to electronic and other controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

TX HB2246

Relating to certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX SB594

Relating to the regulation of prescriptions for controlled substances, including certain procedures applicable to electronic prescriptions for Schedule II controlled substances.

TX HB2174

Relating to controlled substance prescriptions and reimbursement for treatment for certain substance use disorders; authorizing a fee.

TX SB1233

Relating to controlled substance prescriptions under the Texas Controlled Substances Act; authorizing a fee.

LA HB548

Requires that the prescribers transmit prescriptions for opioids to pharmacies electronically (EG SEE FISC NOTE SG EX See Note)